Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -106,373 | -77,762 | -44,920 | -21,960 | -74,013 |
| Depreciation Amortization | -582 | -573 | -410 | -283 | -1,450 |
| Accounts receivable | -45 | 142 | 321 | -93 | -803 |
| Other Working Capital | -18,838 | -12,906 | -13,341 | -7,517 | 43,219 |
| Other Operating Activity | 16,613 | 13,040 | 5,928 | 2,327 | 10,746 |
| Operating Cash Flow | $-109,225 | $-78,059 | $-52,422 | $-27,526 | $-22,301 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -30,498 | -45,236 | 51,645 | 26,410 | -82,746 |
| PPE Investments | -18 | -18 | -18 | -11 | -73 |
| Investing Cash Flow | $-30,516 | $-45,254 | $51,627 | $26,399 | $-82,819 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 142,604 | 142,576 | 4,208 | 234 | 110,813 |
| Financing Cash Flow | $142,604 | $142,576 | $4,208 | $234 | $110,813 |
| Beginning Cash Position | 15,850 | 15,850 | 15,850 | 15,850 | 10,157 |
| End Cash Position | 18,713 | 35,113 | 19,263 | 14,957 | 15,850 |
| Net Cash Flow | $2,863 | $19,263 | $3,413 | $-893 | $5,693 |
| Free Cash Flow | |||||
| Operating Cash Flow | -109,225 | -78,059 | -52,422 | -27,526 | -22,301 |
| Capital Expenditure | -18 | -18 | -18 | -11 | -73 |
| Free Cash Flow | -109,243 | -78,077 | -52,440 | -27,537 | -22,374 |